Specificity, Inc. (SPTY)
| Market Cap | 5.97M -14.3% |
| Revenue (ttm) | 1.09M +18.2% |
| Net Income | -556.78K |
| EPS | -0.04 |
| Shares Out | 17.57M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 70,653 |
| Open | 0.2521 |
| Previous Close | 0.3198 |
| Day's Range | 0.2402 - 0.3400 |
| 52-Week Range | 0.0180 - 1.4000 |
| Beta | 5.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 18, 2026 |
About Specificity
Specificity, Inc. operates as a digital marketing company in the United States and internationally. It offers Tradigital Partners, a specialized white-label digital marketing service for advertising agencies; Put-Thru, a digital marketing tech stack for small and medium-sized businesses; and Pickpocket, a do-it-yourself digital marketing platform for small business owners. The company also provides intuitive ad sequencing, audience ID technology, artificial intelligence integration, saturation modeling, conversion funneling, customer relationsh... [Read more]
Financial Performance
In 2025, Specificity's revenue was $1.09 million, an increase of 9.77% compared to the previous year's $991,143. Losses were -$473,147, -23.10% less than in 2024.
Financial StatementsNews
Scribe Therapeutics Reports Preclinical Data at ASGCT 2026 Demonstrating Enhanced Potency and Specificity of Engineered CRISPR Technologies for Epigenetic Silencing and Gene Editing
ALAMEDA, Calif.--(BUSINESS WIRE)-- #CRISPR--Scribe Therapeutics reports preclinical data at ASGCT 2026 demonstrating enhanced potency and specificity of engineered CRISPR technologies.
Alamar Biosciences Launches NULISAseq™ Neuro 220 Panel, its largest precision proteomics panel with the sensitivity and specificity to advance neurological disease research
New panel expands coverage for Alzheimer's and Parkinson's diseases including 15 new biomarkers developed with support from The Michael J. Fox Foundation for Parkinson's Research (MJFF) and 12 assays ...
Specificity Reports Surge in New Client Partnerships as Strategic Growth Initiatives Begin Delivering Results
SARASOTA, FLORIDA / ACCESS Newswire / March 9, 2026 / Specificity (OTCID:SPTY), a leading performance marketing agency known for its proprietary advertising technology and human verified audience targ...
Specificity (OTCID:SPTY) to Present on the Emerging Growth Conference on February 26th, 2026.
Specificity invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference. SARASOTA, FLORIDA / AC...
Specificity (OTCID: SPTY) Launches Strategic Expansion into $600B Home Services Market with Proprietary Human-Only, Intent-Driven Advertising Platform
SARASOTA, FL / ACCESS Newswire / February 17, 2026 / Specificity (OTCID:SPTY), a full-service advertising agency powered by proprietary AI-driven fraud prevention and real-time intent technology, toda...
Specificity Founder Jason Wood to Host Live X Spaces Discussion on Market Wire News
SARASOTA, FLORIDA / ACCESS Newswire / January 28, 2026 / Specificity (OTCID:SPTY) - Specificity, a performance-driven digital marketing and ad tech firm redefining how brands reach verified human audi...
Specificity Announces Partnership with A2SPA to Secure Agentic AI Execution in AdTech
SARASOTA, FLORIDA / ACCESS Newswire / January 27, 2026 / Specificity (OTCID:SPTY), a leading digital marketing agency specializing in hybrid AdTech solutions, today announced a strategic partnership w...
Specificity Secures Strategic Short-Term Capital Through STRATA Financing to Accelerate Growth and Tech Buildout
SARASOTA, FLORIDA / ACCESS Newswire / January 21, 2026 / Specificity (OTCID:SPTY), a leading hybrid AdTech company revolutionizing digital marketing with bot-free, intent-based targeting and precision...
Specificity Achieves Positive Cash Flow and Unveils Strategic Growth Initiatives for 2026
SARASOTA, FLORIDA / ACCESS Newswire / January 20, 2026 / Specificity (OTCID:SPTY), a leading hybrid AdTech company specializing in bot-free, intent-based digital marketing solutions, today announced a...
Specificity Delivers Wildly Successful First Month for the 3rd Largest Travel Website in Europe, Generating 38X IRR via Human-Verified, Bot-Free Targeting
TAMPA, FL / ACCESS Newswire / December 4, 2025 / Specificity (OTCID:SPTY) The 3rd largest travel website in all of Europe, generating more than $75M annually, partnered with Specificity to leverage th...
Specificity Achieves Positive Operating Cash Flow for November
TAMPA, FLORIDA / ACCESS Newswire / November 24, 2025 / Specificity Inc. (OTCID:SPTY) (the "Company"), a disruptor in the digital marketing space, is pleased to announce that it reached a major milesto...
Specificity Readies for Next Phase of Growth with Effective S-1 Registration Statement Enabling Access to Expansion Capital
Successfully Completes the Company's Process of Regaining Full SEC Compliance TAMPA, FLORIDA / ACCESS Newswire / November 4, 2025 / Specificity Inc. (OTCID:SPTY) (the "Company"), the fast-scaling ad t...
Specificity Signs LOI with Blackpearl Group to Build the World's Only Fully Integrated Ad Tech Stack, Launching a Direct Attack on Big Tech Fraud
TAMPA, FLORIDA / ACCESS Newswire / October 29, 2025 / Specificity (OTCID:SPTY), the leader in precision digital marketing, today announced it has signed a Letter of Intent (LOI) with New Zealand-based...
Specificity Appoints Rob Gagne as Chief Technology Officer to Accelerate Global Expansion and Ad Tech Innovation
TAMPA, FLORIDA / ACCESS Newswire / October 21, 2025 / Specificity (OTCID:SPTY), the fast-scaling ad tech disruptor redefining digital marketing precision, today announced the appointment of Rob Gagne ...
Specificity Appoints Global Executive Leader Robert Fedder as Chief Executive Officer to Drive Next Phase of Scalable Growth
Founder Jason Wood to remain deeply involved as Specificity strengthens executive leadership and accelerates its market expansion. TAMPA, FLORIDA / ACCESS Newswire / October 20, 2025 / Specificity (OT...
Contrast Enhanced Ultrasound Shows 100% Sensitivity and Specificity for Finding Residual or Recurrent Kidney Tumors
CHICAGO--(BUSINESS WIRE)-- #CEUS--Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for fin...
Specificity Prepares to Launch Proprietary AI Tech Stack After Year of Strategic Transformation
TAMPA, FL / ACCESS Newswire / August 13, 2025 / Specificity, Inc. (OTCID:SPTY), a leading digital marketing agency blending proprietary ad tech with cutting-edge strategy, is finalizing development of...
Specificity Expands to Europe, Bringing Precision Targeting and Human-Only Ad Tech to a Market Ripe for Disruption
TAMPA, FLORIDA / ACCESS Newswire / July 30, 2025 / Specificity, Inc. (OTCID:SPTY), the digital marketing powerhouse known as the nation's first, truly hybrid model for adtech and digital marketing, ha...
Oral Cancer Rapid Test Kits Business Report 2025 | Market to Reach $1.2 Billion by 2030 - Advancements in Biomarker Identification Propel Development of High-Specificity Rapid Test Kits
Oral cancer rapid test kits present major opportunities in early diagnosis, driven by non-invasive, saliva-based detection technologies and rising demand in high-risk regions. Trends include use in po...
Specificity Regains Status as a Fully Reporting U.S. Securities and Exchange Commission Current Filer
TAMPA, FLORIDA / ACCESS Newswire / July 22, 2025 / Specificity Inc. (OTCIQ:SPTY) (the "Company"), a disruptor in the digital marketing space, is pleased to announce that it has regained status as a fu...
Tumor Ablation Market Research Report 2025-2032 | Radiofrequency Ablation Leads, Offering Efficiency and Specificity Across Key Organ Treatments
The global tumor ablation market is projected to surge from USD 1.67 billion in 2024 to USD 4.15 billion by 2032. Driven by advancements in minimally invasive techniques like radiofrequency and microw...
Specificity Cracks the Code on Cross-Channel Precision: Video Ads Served to the Same High-Intent, Bot-Free Audiences Engaged on Display and Social
TAMPA, FL / ACCESS Newswire / June 4, 2025 / Specificity (OTC PINK:SPTY) a disruptor in the digital marketing space, has officially closed the loop on precision audience engagement. The company now de...
Specificity Guarantees High-Quality B2B Leads - Disrupting the Broken Lead Gen Model
TAMPA, FLORIDA / ACCESS Newswire / May 28, 2025 / Specificity, Inc. (OTC PINK:SPTY) the digital marketing agency known for crushing industry norms and delivering hyper-targeted campaigns, has official...
Specificity Builds Dominant CTV Campaign Capabilities, Reinforces Position as Industry's Leading Hybrid Marketing Agency
TAMPA, FLORIDA / ACCESS Newswire / May 14, 2025 / Specificity, Inc. (OTC PINK:SPTY), the marketing industry's only true hybrid model agency, today announced the expansion of its cutting-edge Connected...
Clasp Therapeutics Doses First Patient in Phase 1 Clinical Trial With a First-in-Class T-Cell Engager Designed to Target Cancer Cells With Absolute Specificity
CAMBRIDGE, Mass. & ROCKVILLE, Md.--(BUSINESS WIRE)--Clasp Therapeutics doses first patient in the GUARDIAN-101 Phase 1 trial with a first-in-class T-Cell engager designed to target cancer cells.